NEW YORK--(BUSINESS WIRE)-- BTIG announced today that the BTIG Targeted Therapeutics Conference will take place on Monday, February 24, 2020 in New York. The conference will be hosted by BTIG Biotechnology Analysts Tim Chiang, Robert Bert Hazlett, Amanda Murphy, CFA, and Thomas Shrader, PhD, CFA, and BTIG Healthcare Strategy and Franchise Sales Specialists Mikhail Keyserman, CMT, CFTe, and Michael Karmiol. The firms private event will include one-on-one meetings and thematic panels featuring key opinion leaders and leadership team members from several embryonic and mature therapeutic companies in the space.

Some of the topics for discussion include:

Our moderators and panelists are each paving a unique path within the industry. Whether developing innovative therapeutic solutions, caring for patients or being a recognized thought leader, they are tasked with helping others better understand trends, products and whats next within biotechnology, commented David Lenchus, Director of Research at BTIG. We are excited about the lineup of speakers weve attracted for our 2020 event and look forward to helping our clients and partners make more informed trading and investment decisions.

BTIGs Corporate Access program hosts client events across the consumer, energy, financials, healthcare, real estate, shipping and technology, media and telecommunications sectors.

For more information about the conference, email info@btig.com. Please note that participants must be pre-registered to attend.

To access BTIG insights, contact a BTIG representative or visit http://www.btigresearch.com.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 600 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firms core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. Disclaimer: https://www.btig.com/disclaimer.

To learn more about BTIG, visit http://www.btig.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200109005743/en/

See the original post here:
BTIG to Host Targeted Therapeutics Conference on February 24, 2020 in New York - BioSpace

Comments are closed.